摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

rhodamine 6G | 106627-60-5

中文名称
——
中文别名
——
英文名称
rhodamine 6G
英文别名
benzoic acid, 2-[6-(ethylamino)-3-(ethylimino)-2,7-dimethyl-3H-xanthen-9-yl]-, ethyl ester, monohydrochloride;rhodamine 6 G;R6G;(Z)-[9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium;chloride
rhodamine 6G化学式
CAS
106627-60-5
化学式
C28H30N2O3*ClH
mdl
——
分子量
479.019
InChiKey
VYXSBFYARXAAKO-BXMGYBSLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.77
  • 重原子数:
    34.0
  • 可旋转键数:
    6.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    63.83
  • 氢给体数:
    1.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    描述:
    rhodamine 6G一水合肼 作用下, 以 甲醇N,N-二甲基甲酰胺 为溶剂, 反应 12.0h, 生成 玫瑰精-6GN-苯基-硫代氨基甲酰肼
    参考文献:
    名称:
    A Rhodamine-Based Fluorescent and Colorimetric Chemodosimeter for the Rapid Detection of Hg2+ Ions in Aqueous Media
    摘要:
    A rhodamine-based fluorescent and colorimetric chemodosimeter for the rapid detection of Hg2+ ions in aqueous media was developed. The system, which utilizes an irreversible Hg2+-promoted oxadiazole forming reaction, responds instantaneously at room temperature in a 1:1 stoichiometric manner to the amount of Hg2+. The selectivity of this system for Hg2+ over other metal ions is remarkably high, and its sensitivity is below 2 ppb in aqueous solutions.
    DOI:
    10.1021/ja054855t
  • 作为试剂:
    描述:
    三甲氧基磷rhodamine 6G 作用下, 以 乙腈 为溶剂, 生成 磷酸三甲酯
    参考文献:
    名称:
    通过三价磷化合物的单电子转移淬灭光敏染料
    摘要:
    各种类型的三价磷化合物1在水性乙腈中经历单电子转移(SET)到若丹明6G(Rho + *)的光激发态,以猝灭Rho + *发出的荧光。通过Stern-Volmer方法确定整个SET过程的速率常数kp。该速率在E1 / 2(1)<1.3 V(vs Ag / Ag +)区域中的扩散控制极限处几乎恒定,而log kp线性依赖于E1 / 2(1/2)区域中的E1 / 2(1) (1)> 1.3 V,相关线的斜率为α= 0.2的-alphaF / RT。log kp依赖于E1 / 2(1)的变化发生的电势(1.3 V)符合通过实验获得的E1 / 2(Rho + *)(1.22 V)的值。因此,SET步骤在E1 / 2(1)<1.3 V时放热,在E1 / 2(1)> 1.3 V时吸热.α值(0。在吸热区域中获得的2)表明,从1到Rho + *的SET步骤在该区域是不可逆的。在SET步骤中生成的三价磷自由基阳离子1
    DOI:
    10.1021/jo000448i
点击查看最新优质反应信息

文献信息

  • [EN] ELECTROCHEMICALLY-CLEAVABLE LINKERS<br/>[FR] LIEURS CLIVABLES PAR VOIE ÉLECTROCHIMIQUE
    申请人:MICROSOFT TECHNOLOGY LICENSING LLC
    公开号:WO2021158412A1
    公开(公告)日:2021-08-12
    This disclosure provides electrochemically-cleavable linkers with cleavage potentials that are less than the redox potential of the solvent in which the linkers are used. In some applications, the solvent may be water or an aqueous buffer solution. The linkers may be used to link a nucleotide to a bound group. The linkers include a cleavable group which may be one of a methoxybenzyl alcohol, an ester, a propargyl thioether, or a trichloroethyl ether. The linkers may be cleaved in solvent by generating an electrode potential that is less than the redox potential of the solvent. In some implementations, an electrode array may be used to generate localized electrode potentials which selectively cleave linkers bound to the activated electrode. Uses for the linkers include attachment of blocking groups to nucleotides in enzymatic oligonucleotide synthesis.
    这份披露提供了具有低于使用的溶剂的氧化还原电位的可电化学裂解连接物。在某些应用中,溶剂可能是水或水溶液缓冲液。这些连接物可用于将核苷酸连接到结合基团。连接物包括可裂解基团,可能是甲氧基苯甲醇、酯、丙炔硫醚或三氯乙基醚中的一种。通过产生低于溶剂的氧化还原电位的电极电位,可以在溶剂中裂解这些连接物。在某些实施中,可以使用电极阵列来产生局部电极电位,从而选择性地裂解与激活电极结合的连接物。这些连接物的用途包括在酶催化寡核苷酸合成中将阻断基团附着到核苷酸上。
  • IRAK DEGRADERS AND USES THEREOF
    申请人:Kymera Therapeutics, Inc.
    公开号:US20190192668A1
    公开(公告)日:2019-06-27
    The present invention provides compounds, compositions thereof, and methods of using the same.
    本发明提供了化合物、其组合物以及使用这些化合物的方法。
  • [EN] FLUOROPHORE COMPOUNDS<br/>[FR] COMPOSÉS FLUOROPHORES
    申请人:VERSITECH LTD
    公开号:WO2009121244A1
    公开(公告)日:2009-10-08
    Provided herein are fluorophore compounds including rhodol and rhodamine compounds which can be used as fluorescent labels and/or fluorogenic probes and methods of making same. Provided also herein are methods that can be used to track, measure, detect, or screen biological species such as protein, DNA, enzyme, antibody, organelle, cell, tissue, drug, hormone, nucleotide, nucleic acid, polysaccharide or lipid in living organisms. Specifically, the methods include the steps of contacting any of the fluorophore compounds, rhodol compounds and rhodamine compounds disclosed herein with the biological species to form one or more fluorescent compounds, and measuring fluorescence properties of the fluorescent compounds. Provided also herein are high-throughput screening fluorescent methods for detecting or screening biological species.
    本文提供了包括罗多尔和罗丹明化合物在内的荧光物质,可用作荧光标记剂和/或荧光探针,并提供了制备这些化合物的方法。本文还提供了可用于跟踪、测量、检测或筛选蛋白质、DNA、酶、抗体、细胞器、细胞、组织、药物、激素、核苷酸、核酸、多糖或脂质等生物种类在活体中的方法。具体而言,这些方法包括将本文披露的任何荧光物质、罗多尔化合物和罗丹明化合物与生物种类接触以形成一个或多个荧光化合物,并测量荧光化合物的荧光特性。本文还提供了用于检测或筛选生物种类的高通量筛选荧光方法。
  • [EN] COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS<br/>[FR] COMPOSÉS UTILES POUR LE TRAITEMENT DE TROUBLES NEURODÉGÉNÉRATIFS
    申请人:SATORI PHARMACEUTICALS INC
    公开号:WO2011109657A1
    公开(公告)日:2011-09-09
    As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.
    如本文所述,本发明提供了用于治疗或减轻神经退行性疾病严重程度的化合物。本发明还提供了治疗或减轻此类疾病严重程度的方法,其中所述方法包括向患者施用本发明的化合物或其组合物。该方法适用于治疗或减轻例如阿尔茨海默病等疾病的严重程度。
  • [EN] IRAK DEGRADERS AND USES THEREOF<br/>[FR] AGENTS DE DÉGRADATION D'IRAK ET LEURS UTILISATIONS
    申请人:KYMERA THERAPEUTICS INC
    公开号:WO2020264499A1
    公开(公告)日:2020-12-30
    The present invention provides compounds, compositions thereof, and methods of using the same. The compounds include an IRAK binding moiety capable of binding to IRAK4 and a degradation inducing moiety (DIM). The DIM could be DTM a ligase binding moiety (LBM) or lysine mimetic. The compounds could be useful as IRAK protein kinase inhibitors and applied to IRAK mediated disorders.
    本发明提供了化合物、其组合物以及使用这些化合物的方法。这些化合物包括能够结合到IRAK4的IRAK结合基团和诱导降解的基团(DIM)。DIM可以是DTM、一个连接酶结合基团(LBM)或赖氨酸类似物。这些化合物可以作为IRAK蛋白激酶抑制剂,并应用于IRAK介导的疾病。
查看更多